Nuvalent, Inc. (NUVL)
Nuvalent Market Cap : 7.378B for March 3, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Glaukos Corp. | 6.798B |
| Edgewise Therapeutics, Inc. | 3.142B |
| Neurocrine Biosciences, Inc. | 13.24B |
| Vanda Pharmaceuticals, Inc. | 470.50M |
| Kodiak Sciences, Inc. | 1.624B |
Market Cap Related Metrics
| PEG Ratio | -0.3504 |
| Price to Book Value | 5.910 |
| Price | 101.48 |
| Earnings Yield | -5.77% |
| PEGY Ratio | -0.3504 |